Back to Screener

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (QNTM)

NASDAQ Nano Cap

Healthcare › Pharmaceutical Preparations

$3.98
Market Cap: $286
Data as of Dec 31, 2025

Price History

Feb 9, 2026 — Apr 3, 2026

Investment Snapshot

  • P/B of 0.00 — trading below book value
  • Piotroski F-Score 3/9 — signs of financial weakness

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (QNTM) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $0 million . Key value metrics: P/B ratio 0.00, Piotroski F-Score 3 out of 9 .

Value Score

Key Metrics

P/E Ratio
0.00
EPS
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares — Fundamental Analysis Summary

On financial health, QNTM shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and minimal leverage with a debt-to-equity ratio of 0.25.

StockPik's composite Value Score for QNTM is 75/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CYRX $8.21 4.7 100
CRMD $6.70 3.6 100
CGEN $2.06 5.5 100
ABEO $4.82 4.5 100
BDMD $2.01 5.8 100
Stocks below book value
Other stocks trading at a discount to net assets (P/B < 1)
How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
QNST
Next
QRHC